METALLOPROTEASES AND SERINE PROTEASES ARE INVOLVED IN THE CLEAVAGE OFTHE 2 TUMOR-NECROSIS-FACTOR (TNF) RECEPTORS TO SOLUBLE FORMS IN THE MYELOID CELL-LINES U-937 AND THP-1
F. Bjornberg et al., METALLOPROTEASES AND SERINE PROTEASES ARE INVOLVED IN THE CLEAVAGE OFTHE 2 TUMOR-NECROSIS-FACTOR (TNF) RECEPTORS TO SOLUBLE FORMS IN THE MYELOID CELL-LINES U-937 AND THP-1, Scandinavian journal of immunology, 42(4), 1995, pp. 418-424
The proteolytic processing of the two TNF receptors (TNF-R55 and TNF-R
75) into soluble forms was investigated in the myeloid cell lines U-93
7 and THP-1. Phorbol myristate acetate (PMA) rapidly stimulated releas
e of soluble forms of both TNF-receptors. Incubations were made with P
MA and protease inhibitors directed against different target protease
groups. The serineprotease inhibitors TPCK and dichloroisocoumarin and
the metalloprotease inhibitor 1,10-phenanthroline reduced PMA-induced
release of both soluble receptor forms with about 60-70%. Furthermore
, 1,10-phenanthroline also reduced PMA-induced down-regulation of TNF-
receptors in both cell lines as judged by TNF-binding to cells. Reduce
d down-regulation and TNF-receptor shedding by 1,10-phenanthroline was
reversed by Zn2+, indicating involvement of a Zn2+-dependent metallop
rotease. Thus, both serine proteases and metalloproteases are involved
in the processing of TNF-receptors.